Skip to main content
. 2012 Jun 9;2012(1):18. doi: 10.1186/1687-9856-2012-18

Figure 1.

Figure 1

Scatter plots of sodium levels during 3.9 months on oral DDAVP (n = 106) compared with the subsequent 2.5 months on the new regimen of twice-daily subcutaneous DDAVP with sliding scale fluid prescription, adjusted according to the results of home sodium monitoring (n = 98). Median and interquartile range for sodium levels on each regimen are also shown.